Cargando…

A shared mucosal gut microbiota signature in primary sclerosing cholangitis before and after liver transplantation

Several characteristic features of the fecal microbiota have been described in primary sclerosing cholangitis (PSC), whereas data on mucosal microbiota are less consistent. We aimed to use a large colonoscopy cohort to investigate key knowledge gaps, including the role of gut microbiota in PSC with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hole, Mikal Jacob, Jørgensen, Kristin Kaasen, Holm, Kristian, Braadland, Peder R., Meyer‐Myklestad, Malin Holm, Medhus, Asle Wilhelm, Reikvam, Dag Henrik, Götz, Alexandra, Grzyb, Krzysztof, Boberg, Kirsten Muri, Karlsen, Tom Hemming, Kummen, Martin, Hov, Johannes R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Original Articles: Immune-Mediated Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936983/ https://www.ncbi.nlm.nih.gov/pubmed/36056902 http://dx.doi.org/10.1002/hep.32773

Ejemplares similares

Suppression of bile acid synthesis as a tipping point in the disease course of primary sclerosing cholangitis
por: Braadland, Peder Rustøen, et al.
Publicado: (2022)

Autotaxin activity predicts transplant-free survival in primary sclerosing cholangitis
por: Dhillon, Amandeep K., et al.
Publicado: (2019)

Human Immunodeficiency Virus–Infected Immunological Nonresponders Have Colon-Restricted Gut Mucosal Immune Dysfunction
por: Meyer-Myklestad, Malin Holm, et al.
Publicado: (2020)

Impact on follow‐up strategies in patients with primary sclerosing cholangitis
por: Bergquist, Annika, et al.
Publicado: (2022)

A novel serum metabolomic panel distinguishes IgG4‐related sclerosing cholangitis from primary sclerosing cholangitis
por: Radford‐Smith, Daniel E., et al.
Publicado: (2022)

Refinement of the MHC Risk Map in a Scandinavian Primary Sclerosing Cholangitis Population
por: Næss, Sigrid, et al.
Publicado: (2014)

The Simple Cholestatic Complaints Score is a valid and quick patient‐reported outcome measure in primary sclerosing cholangitis
por: van Munster, Kim N., et al.
Publicado: (2020)

Emerging therapies in primary sclerosing cholangitis: pathophysiological basis and clinical opportunities
por: Vesterhus, Mette, et al.
Publicado: (2020)

Increased expression of the urokinase plasminogen activator system by Helicobacter pylori in gastric epithelial cells
por: Kenny, Susan, et al.
Publicado: (2008)

EP(2) and EP(4) receptors on muscularis resident macrophages mediate LPS-induced intestinal dysmotility via iNOS upregulation through cAMP/ERK signals
por: Tajima, Tsuyoshi, et al.
Publicado: (2012)

Intestinal epithelial suppressor of cytokine signaling 3 enhances microbial-induced inflammatory tumor necrosis factor-α, contributing to epithelial barrier dysfunction
por: Thagia, Imtiyaz, et al.
Publicado: (2014)

Circulating Macrophage Activation Markers Predict Transplant-Free Survival in Patients With Primary Sclerosing Cholangitis
por: Bossen, Lars, et al.
Publicado: (2021)

Secondary sclerosing cholangitis following COVID-19 disease: a multicenter retrospective study
por: Hunyady, Peter, et al.
Publicado: (2022)

Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis
por: Rühlemann, Malte, et al.
Publicado: (2019)

Enhanced Gut-Homing Dynamics and Pronounced Exhaustion of Mucosal and Blood CD4(+) T Cells in HIV-Infected Immunological Non-Responders
por: Lorvik, Kristina Berg, et al.
Publicado: (2021)

Gut mycobiome of primary sclerosing cholangitis patients is characterised by an increase of Trichocladium griseum and Candida species
por: Rühlemann, Malte Christoph, et al.
Publicado: (2020)

Effective treatment of canine chronic cutaneous lupus erythematosus variants with oclacitinib: Seven cases
por: Harvey, Richard G., et al.
Publicado: (2022)

Gut and Liver B Cells of Common Clonal Origin in Primary Sclerosing Cholangitis–Inflammatory Bowel Disease
por: Chung, Brian K., et al.
Publicado: (2018)

Electrostatic Modifications of the Human Leukocyte Antigen-DR P9 Peptide-Binding Pocket and Susceptibility to Primary Sclerosing Cholangitis
por: Hov, Johannes R, et al.
Publicado: (2011)

Indications and Outcomes in Liver Transplantation in Patients With Primary Sclerosing Cholangitis in Norway
por: Andersen, Ina M., et al.
Publicado: (2015)

Utility of fluorescence imitating brightfield imaging microscopy for the diagnosis of feline chronic enteropathy
por: Au Yeung, Sarah, et al.
Publicado: (2022)

Portal pressure is of significant prognostic value in primary biliary cholangitis
por: Warnes, Thomas W., et al.
Publicado: (2022)

Secondary sclerosing cholangitis: mimics of primary sclerosing cholangitis
por: Ludwig, Daniel R., et al.
Publicado: (2022)

Reduction and stabilization of bilirubin with obeticholic acid treatment in patients with primary biliary cholangitis
por: Parés, Albert, et al.
Publicado: (2020)

Cholangiocytes and the environment in primary sclerosing cholangitis: where is the link?
por: O’Hara, Steven P, et al.
Publicado: (2017)

Catalytically impaired hMYH and NEIL1 mutant proteins identified in patients with primary sclerosing cholangitis and cholangiocarcinoma
por: Forsbring, Monika, et al.
Publicado: (2009)

Combination antiretroviral therapy improves recurrent primary biliary cholangitis following liver transplantation
por: Lytvyak, Ellina, et al.
Publicado: (2021)

IgG4-Related Sclerosing Cholangitis and Primary Sclerosing Cholangitis
por: Tanaka, Atsushi
Publicado: (2019)

High prevalence of lower limb atherosclerosis is linked with the gut–liver axis in patients with primary biliary cholangitis
por: Ponziani, Francesca Romana, et al.
Publicado: (2022)

Predictors of serious adverse events and non‐response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid
por: De Vincentis, Antonio, et al.
Publicado: (2022)

Mutational Characterization of the Bile Acid Receptor TGR5 in Primary Sclerosing Cholangitis
por: Hov, Johannes R., et al.
Publicado: (2010)

Primary sclerosing cholangitis.
por: Spence, R. A., et al.
Publicado: (1984)

Primary sclerosing cholangitis
por: Worthington, Joy, et al.
Publicado: (2006)

Early and accurate detection of cholangiocarcinoma in patients with primary sclerosing cholangitis by methylation markers in bile
por: Vedeld, Hege Marie, et al.
Publicado: (2021)

Fluctuating biomarkers in primary sclerosing cholangitis: A longitudinal comparison of alkaline phosphatase, liver stiffness, and ELF
por: Fossdal, Guri, et al.
Publicado: (2021)

Quantitative bile and serum proteomics for the screening and differential diagnosis of primary sclerosing cholangitis
por: Holm, Matilda, et al.
Publicado: (2022)

IL‐31 levels correlate with pruritus in patients with cholestatic and metabolic liver diseases and is farnesoid X receptor responsive in NASH
por: Xu, Jun, et al.
Publicado: (2023)

CD8(+) T cell memory is sustained in mice by hepatic stellate cells
por: Chen, Yi‐Ting, et al.
Publicado: (2023)

The immunobiology of primary sclerosing cholangitis
por: Aron, Jonathan H., et al.
Publicado: (2009)

Pathogenesis of primary sclerosing cholangitis
por: Pollheimer, Marion J., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_pl6lh6tao32k1dk9duotctlump